Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPLE: atogepant versus topiramate for preventive treatment of migraine
MOH_2023-05-28_012678Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Atogepant arm with Topiramate arm (2 arms). Started Feb 2023; status: active, not recruiting.
02
Drugs
atogepanttopiramate
03
Conditions
migraine
Beyond the preview
Go deeper on MOH_2023-05-28_012678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-05-28_012678.